The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT-EHA CAR-T 2019 | Promising areas of CAR T-cell therapy
Christine Chomienne
• 8 Mar 2019
Speaking at the 1st European CAR T-Cell Meeting, held in Paris, France, Christine Chomienne, MD, PhD, of St. Louis Hospital, Paris, France, sheds light on the promising areas regarding CAR T-cell therapy. This meeting was co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).
